All Circulars (28174)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE notifies listing of further issued securities for 14 companies including Aditya Birla Capital, Axis Bank, Black Box Limited, and others, … | |||||||||||||||
NSE notifies listing of further issued securities for 14 companies including Aditya Birla Capital, Axis Bank, Black Box Limited, and others, effective May 08, 2026.
| |||||||||||||||
NSE admits two privately placed debt securities to dealings on the capital market segment effective May 08, 2026, including bonds from … | |||||||||||||||
NSE admits two privately placed debt securities to dealings on the capital market segment effective May 08, 2026, including bonds from Cholamandalam Investment and Finance Company and Master Capital Services Limited.
| |||||||||||||||
NSE adds 9 securities to ST-ASM Stage I effective May 08, 2026, with enhanced margin requirements of 50% or existing margin (whichever … | |||||||||||||||
NSE adds 9 securities to ST-ASM Stage I effective May 08, 2026, with enhanced margin requirements of 50% or existing margin (whichever higher) applicable from May 11, 2026. No securities added to Stage II.
| |||||||||||||||
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from … | |||||||||||||||
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from 8th May 2026 to 14th May 2026, with an offer price of Rs. 250 per share for up to 16,00,000 equity shares.
| |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 … | |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 equity shares at Rs.250 per share for an aggregate consideration not exceeding Rs.40 crores.
| |||||||||||||||
BSE notifies trading members that SRG Housing Finance Limited has fixed a record date for payment of interest and part redemption of its … | |||||||||||||||
BSE notifies trading members that SRG Housing Finance Limited has fixed a record date for payment of interest and part redemption of its Non-Convertible Debentures, with trading to continue at reduced face value from the ex-date.
| |||||||||||||||
BSE directs all active Trading Members to renew their Indemnity Insurance Policy with a minimum sum insured of Rs. 5 lakhs and submit … | |||||||||||||||
BSE directs all active Trading Members to renew their Indemnity Insurance Policy with a minimum sum insured of Rs. 5 lakhs and submit details on BEFS portal within 30 days of expiry. Non-compliance will invite disciplinary action.
| |||||||||||||||
NSE Clearing Limited revises Market Wide Position Limit (MWPL) and participant/client limits for EFCIL in the Securities Lending and … | |||||||||||||||
NSE Clearing Limited revises Market Wide Position Limit (MWPL) and participant/client limits for EFCIL in the Securities Lending and Borrowing Scheme, effective May 08, 2026.
| |||||||||||||||
NSE resumes subscriptions including lumpsum purchase, Switch-in, and fresh SIP/STP registrations in three Invesco India Fund of Fund schemes … | |||||||||||||||
NSE resumes subscriptions including lumpsum purchase, Switch-in, and fresh SIP/STP registrations in three Invesco India Fund of Fund schemes effective May 08, 2026 on the NSE MF Invest Platform.
| |||||||||||||||
RTI first appeal filed by Saurabhi Bharat Rele seeking clarifications on SEBI Circular CIR/IMD/DF/21/2012 regarding mutual fund direct plans … | |||||||||||||||
RTI first appeal filed by Saurabhi Bharat Rele seeking clarifications on SEBI Circular CIR/IMD/DF/21/2012 regarding mutual fund direct plans pre-January 2013. Appeal dismissed as time-barred and queries held to be opinion/clarification-seeking, not 'information' under RTI Act.
| |||||||||||||||